Observing patient management for lymphoma at Nîmes University Hospital over 20 years
Evaluation of the Efficacy of Management of Patients With Lymphomas Diagnosed at Nimes University Hospital Over 20 Years (1999-2018) Under Real-life Circumstances
This study looks at how 400 lymphoma patients were treated over 20 years at Nîmes University Hospital to see how their other health issues and access to care affected their outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Ages | 15 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Nīmes Academic / other |
| Locations | 1 site (Nîmes) |
| Trial ID | NCT04947618 on ClinicalTrials.gov |
What this trial studies
This observational study analyzes a cohort of 400 patients diagnosed with various types of lymphomas at Nîmes University Hospital from 1999 to 2018. The study aims to build a comprehensive database that includes biopsies and frozen samples of tumors to better understand the diverse management of lymphoma patients. By focusing on a non-selected cohort, the study seeks to evaluate how comorbidities and treatment accessibility affect patient outcomes, highlighting the limitations of current management recommendations. The goal is to provide insights into the real-world management of lymphoma patients, which may differ from established guidelines.
Who should consider this trial
Good fit: Ideal candidates include individuals over 15 years old diagnosed with lymphoma at Nîmes University Hospital since 1999, with available diagnostic tumor material.
Not a fit: Patients who have opted out of participation or those under legal guardianship will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve understanding of lymphoma management and lead to more tailored treatment approaches for patients.
How similar studies have performed: While observational studies on lymphoma management exist, this specific approach focusing on a non-selected cohort is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over the age of 15 years and 3 months, diagnosed with lymphoma at Nîmes University Hospital as from 1999 onwards and for whom diagnostic tumor material is available. Exclusion Criteria: * Patients aged 18 or over who have expressed their desire not to take part in the study. * Patients under the age of 18 whose legal representatives have expressed their desire for the child not to take part in the study. * Patients under legal guardianship.
Where this trial is running
Nîmes
- CHU Nimes — Nîmes, France (Recruiting)
Study contacts
- Study coordinator: Eric JOURDAN, Dr.
- Email: eric.jourdan@chu-nimes.fr
- Phone: 0466684033
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.